Kaiser Permanente faces more than $2.5 million in penalties for its alleged failure to supply California state regulators with properly formatted claims data from Kaiser's Medicaid managed-care plans.
Marathon Pharmaceuticals will temporarily halt the rollout of a drug to treat genetic muscle deterioration after facing criticism over their plan to charge $89,000 a year for a drug that's widely available abroad for about $1,000 a year.
The Veterinary Health Center at Kansas State University has just performed its first surgical implant of a pacemaker in a 4-year-old ferret named Zelda. Surprisingly, Zelda isn't the first ferret to undergo the procedure, but it's an extremely rare occurrence.
Devicemaker Royal Philips has signed a strategic partnership with its largest health system yet.
At cutting-edge healthcare organizations, precision medicine is beginning to affect patient's lives. But most of the healthcare industry is still struggling to overcome significant social, economic and technical barriers to widespread adoption of genetics-based patient care.